<DOC>
	<DOCNO>NCT00269568</DOCNO>
	<brief_summary>This multicenter , randomize study . 564 healthy woman , age 18 year old , intrauterine pregnancy , request medical abortion , recruit participate prospective clinical trial . This study provide evaluation oral mifepristone 200 mg vaginal misoprostol 800 mcg administer simultaneously woman 63 day gestation . The aim study compare complete abortion rate , 7 14 day misoprostol administration , use mifepristone 200 mg orally misoprostol 800 mcg vaginally administer simultaneously 24 hour apart woman 63 day gestation . Assessment side effect ( nausea , vomit , pain ) well acceptability do use pre post-study questionnaire , visual analogue scale . Complete abortion rate within 24 hour expect 90 %</brief_summary>
	<brief_title>Mifepristone Same Time Multicenter Study</brief_title>
	<detailed_description>This multicenter , randomize study . 564 healthy woman , age 18 year old , intrauterine pregnancy , request medical abortion , recruit participate prospective clinical trial . This study provide evaluation oral mifepristone 200 mg vaginal misoprostol 800 mcg administer simultaneously woman 63 day gestation . The aim study compare complete abortion rate , 7 14 day misoprostol administration , use mifepristone 200 mg orally misoprostol 800 mcg vaginally administer simultaneously 24 hour apart woman 63 day gestation . Assessment side effect ( nausea , vomit , pain ) well acceptability do use pre post-study questionnaire , visual analogue scale . Complete abortion rate within 24 hour expect 90 % .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>pregnancy equal le 63 day enrollment abnormal pregnancy diagnose ultrasound</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>medical abortion</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
</DOC>